Specifications
| Item Number | 616646 |
|---|
| Administration Form | Oral |
|---|
| For Use With | Dogs |
|---|
| Generic Name | Pimobendan |
|---|
| Lifestage | Adult， Senior |
|---|
| Product Form | Chewable Tablet |
|---|
| Health Condition | Congestive Heart Failure |
|---|
| Drug Type | Inodilator |
|---|
Uses
VETMEDIN®-CA1 (pimobendan) chewable tablets is conditionally approved for the treatment of dogs with myxomatous mitral valve disease (MMVD) in the pre-clinical stage B2 (asymptomatic with a murmur/abnormal heart sounds and evidence of increased heart size) to delay onset of clinical signs of heart failure. Conditionally approved by FDA pending a full demonstration of effectiveness under application number 141-556 (please see full prescribing information).
Possible Side Effects
VETMEDIN®-CA1 (pimobendan) may cause side effects， even at the prescribed dose. Contact your veterinarian immediately if your dog develops a serious or concerning medical problem or side effect while taking VETMEDIN®-CA1.The most common side effects seen in dogs with Stage B2 MMVD while taking VETMEDIN®-CA1 Chewable Tablets are cough， vomiting， diarrhea， lethargy (lack of energy)， and localized pain (such as in the neck or legs). For full side effects， please refer to the full prescribing information.
Drug & Food Interactions
VETMEDIN®-CA1 (pimobendan) Chewable Tablets is only for use in dogs diagnosed with myxomatous mitral valve disease (MMVD) at a stage known as B2 (asymptomatic with a murmur and evidence of increased heart size). VETMEDIN®-CA1 is not for use in humans: keep this and all medications out of reach of children and consult a physician in case of accidental ingestion. VETMEDIN®-CA1 should only be used in accordance with instructions from your veterinarian. The most common side effects seen in dogs with Stage B2 MMVD while taking VETMEDIN®-CA1 Chewable Tablets are cough， vomiting， diarrhea， lethargy (lack of energy)， and localized pain (such as in the neck or legs). VETMEDIN®-CA1 may cause side effects， even at the prescribed dose. Contact your veterinarian immediately if your dog develops a serious or concerning medical problem or side effect while taking VETMEDIN®-CA1. The safety of VETMEDIN®-CA1 has not been established in puppies younger than 6 months of age， or in breeding， pregnant or lactating dogs.
The safety of VETMEDIN®-CA1 has not been established in dogs with asymptomatic heart disease caused by etiologies other than MMVD. The safe use of VETMEDIN®-CA1 has not been evaluated in MMVD. The safe use of VETMEDIN®-CA1 has not been evaluated in dogs younger than 6 months of age， dogs with congenital heart defects， dogs with diabetes mellitus or other serious metabolic diseases， dogs used for breeding， or pregnant or lactating bitches. For more information， please see full prescribing information.
Precautions
Federal law restricts this drug to use by or on the order of a licensed veterinarian. It is a violation of Federal Law to use VETMEDIN®-CA1 (pimobendan) Chewable Tablets other than as directed in labeling.
Comment